OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
July 01, 2020
Data and science must guide FDA in making pressure-filled COVID-19 vaccine and therapy approval decisions.
June 01, 2020
Therapies for early and late treatment and passive immunization of COVID-19 are needed and can be developed using antibodies from recovered patients.
April 14, 2020
With the acquisition, Orgenesis will combine TamirBio’s ranpirnase antiviral platform with its Bioxome technology.
April 01, 2020
As a result of the rising use and development of biological drugs, the biopharma industry is witnessing an increase in the adoption of prefilled syringes.
March 01, 2020
Contract service organizations can offer biopharma companies early insight into dangers that may hinder a drug’s later development.
February 13, 2020
The companies have entered into a global licensing and collaboration agreement to commercialize ReForm excipients used in biotherapeutic formulations.
February 01, 2020
Biologics raise unique formulation and development challenges, and industry is still on a learning curve to get the best out of these diverse and complex therapies.
January 01, 2020
This study aims to use plant-leaf extract for the green synthesis of gold nanoparticles and to evaluate their antibacterial and antioxidant activity.
December 06, 2019
The new Technology Excellence Center, located in Boston, MA, will further the company’s presence in the United States biopharma drug development landscape.
November 22, 2019
BASF launches digital solutions for the pharma industry during CPhI Worldwide 2019.